FABP3 and cardiomyopathy: Novel cardiovascular biomarkers such as GDF-15, H-FABP and sST-2 offer a differential diagnostic value for distinguishing between TTC, DCMP or ICMP and could help in the identification of unclear cardiomyopathies.